gabapentin

Generic: gabapentin

Labeler: creekwood pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler creekwood pharmaceuticals llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

gabapentin 300 mg/1

Manufacturer
Creekwood Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 82619-143
Product ID 82619-143_26aae270-f035-5159-e063-6394a90a5376
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204989
Listing Expiration 2026-12-31
Marketing Start 2024-09-01

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 82619143
Hyphenated Format 82619-143

Supplemental Identifiers

RxCUI
310430 310431 310432
UPC
0382619142020 0382619143034 0382619143027 0382619144017 0382619146011 0382619144024 0382619142013 0382619143010 0382619145014 0382619142037 0382619146028 0382619145021
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA204989 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (82619-143-01)
  • 500 CAPSULE in 1 BOTTLE (82619-143-02)
  • 1000 CAPSULE in 1 BOTTLE (82619-143-03)
source: ndc

Packages (3)

82619-143-01 100 CAPSULE in 1 BOTTLE (82619-143-01) 82619-143-02 500 CAPSULE in 1 BOTTLE (82619-143-02) 82619-143-03 1000 CAPSULE in 1 BOTTLE (82619-143-03)

Ingredients (1)

gabapentin (300 mg/1)

Linked Drug Pages (1)

Gabapentin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "26aae270-f035-5159-e063-6394a90a5376", "openfda": {"nui": ["N0000008486"], "upc": ["0382619142020", "0382619143034", "0382619143027", "0382619144017", "0382619146011", "0382619144024", "0382619142013", "0382619143010", "0382619145014", "0382619142037", "0382619146028", "0382619145021"], "unii": ["6CW7F3G59X"], "rxcui": ["310430", "310431", "310432"], "spl_set_id": ["26aac429-a5cd-33cc-e063-6394a90aecc0"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Creekwood Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (82619-143-01)", "package_ndc": "82619-143-01", "marketing_start_date": "20240901"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (82619-143-02)", "package_ndc": "82619-143-02", "marketing_start_date": "20240901"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (82619-143-03)", "package_ndc": "82619-143-03", "marketing_start_date": "20240901"}], "brand_name": "Gabapentin", "product_id": "82619-143_26aae270-f035-5159-e063-6394a90a5376", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "82619-143", "generic_name": "Gabapentin", "labeler_name": "Creekwood Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA204989", "marketing_category": "ANDA", "marketing_start_date": "20240901", "listing_expiration_date": "20261231"}